MoonLake Immunotherapeutics
$9.55
-0.71 (-6.92%)
Price as of Oct 16, 2026 market close
Performance
- 1 Month
- -22.7%
- 3 Months
- -49.9%
- YTD
- -27.5%
- 1 Year
- -3.4%
- 3 Year annualized
- -46.0%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 71.7%
- Largest decline max drawdown, since Oct 2021
- -90.2%
- Risk-adjusted return Sharpe ratio, 1-year
- 0.29
Own MLTX?
See how MLTX contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.